Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-16-100493
Filing Date
2016-11-10
Accepted
2016-11-10 12:27:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27663
  Complete submission text file 0000000000-16-100493.txt   38804
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filed for) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations